David Parry
Private Equity Investor chez Samsara Biocapital LLC
Postes actifs de David Parry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Private Equity Investor | 01/10/2021 | - |
Historique de carrière de David Parry
Anciens postes connus de David Parry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| GSK PLC | Corporate Officer/Principal | 01/07/2019 | 01/10/2021 |
| PORTOLA PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 01/12/2011 | 01/03/2013 |
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2009 | 01/01/2011 |
Schering-Plough Biopharma
 Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Corporate Officer/Principal | 01/01/2005 | 01/01/2009 |
Formation de David Parry
| University of Manchester Institute of Science & Technology | Undergraduate Degree |
| Imperial Cancer Research Fund Trading Ltd. | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 5 |
| Royaume-Uni | 4 |
Opérationnelle
| Corporate Officer/Principal | 3 |
| Private Equity Investor | 1 |
| Director/Board Member | 1 |
Sectorielle
| Health Technology | 4 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| MERCK & CO., INC. | Health Technology |
| GSK PLC | Health Technology |
| Entreprise privées | 3 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Portola Pharmaceuticals, Inc. engaged in the development and commercialization of novel therapeutics in the areas of thrombosis, other hematologic disorders, and inflammation. It offers Andexxa and Bevyxxa medicines. The company was founded by Charles J. Homcy and David R. Philips on September 2, 2003 and is headquartered in South San Francisco, CA. | Health Technology |
Schering-Plough Biopharma
Schering-Plough Biopharma Miscellaneous Commercial ServicesCommercial Services Part of Merck & Co., Inc., Schering-Plough Biopharma is a company that provides pharmaceutical research services. The company is based in Kenilworth, NJ. | Commercial Services |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara Biocapital LLC (Samsara Biocapital) is an independent venture capital firm founded in 2016 by Srinivas Akkaraju. The firm is headquartered in Palo Alto, California. | Finance |
- Bourse
- Insiders
- David Parry
- Expérience
